Presentation is loading. Please wait.

Presentation is loading. Please wait.

Bleeding and Thrombotic Disorders.

Similar presentations


Presentation on theme: "Bleeding and Thrombotic Disorders."— Presentation transcript:

1 Bleeding and Thrombotic Disorders

2 Bleeding and Thrombotic Disorders
Bleeding disorders von Willebrand disease Hemophilia A and B DIC TTP/HUS ITP Thrombotic disorders Factor V Leiden

3 Platelet bleeding Superficial (skin) Petechiae Spontaneous Factor bleeding Deep (joints) Big bleeds Trauma * * Includes prolonged bleeding after dental work

4 Petechiae

5 Palatal petechiae

6 Palatal ecchymosis

7 Purpura

8 Bleeding after buttock injection in patient with hemophilia

9 Bleeding and Thrombotic Disorders
Bleeding disorders von Willebrand disease

10 Von Willebrand Disease
Things you must know Most common hereditary bleeding disorder Autosomal dominant vW factor decreased (or abnormal) Variable severity

11 What’s von Willebrand Factor?
Huge multimeric protein Made by megakaryocytes and endothelial cells Glues platelets to endothelium Carries factor VIII Decreased or abnormal in vW disease It arises from a qualitative or quantitative deficiency of von Willebrand factor (vWF), a multimeric protein that is required for platelet adhesion.

12

13 clot Intrinsic Extrinsic X thrombin fibrin
TF VII IX VIII X V thrombin Factor VIII levels are also performed because factor VIII is bound to vWF which protects the factor VIII from rapid breakdown within the blood. Deficiency of vWF can therefore lead to a reduction in factor VIII levels, which explains the elevation in PTT time. Partial thromboplastin time (PTT) is a blood test that looks at how long it takes for blood to clot. fibrin clot

14 Symptoms of Von Willebrand Disease
Mucosal bleeding in most patients Deep joint bleeding in severe cases

15 Lab Tests in Von Willebrand Disease
Bleeding time: prolonged

16 Bleeding and Thrombotic Disorders
Bleeding disorders von Willebrand disease Hemophilia A and B

17 Hemophilia A Things you must know Most common factor deficiency
X-linked recessive in most cases (30% are spontaneous mutations) Factor VIII level decreased Variable amount of “factor” bleeding

18

19

20

21

22 Intrinsic Extrinsic TF VII IX VIII X V thrombin fibrin clot

23 Deep joint bleeding in patient with hemophilia

24 Knee of patient with hemophilia
Normal knee Knee of patient with hemophilia Hemophilic arthropathy of knee

25 Joint Deformity in Hemophilia

26 Hemophilia A Lab tests PTT prolonged Factor VIII level low
DNA studies abnormal Treatment DDAVP Factor VIII

27 Hemophilia B Things you must know Factor IX level decreased
Much less common than hemophilia A Same inheritance pattern Same clinical and laboratory findings

28 Intrinsic Extrinsic TF VII IX VIII X V thrombin fibrin clot

29 Bleeding and Thrombotic Disorders
Bleeding disorders von Willebrand disease Hemophilia A and B DIC Disseminated intravascular coagulation (DIC) is a serious disorder in which the proteins that control blood clotting become over active.

30 Small blood clots form in the blood vessels
Small blood clots form in the blood vessels. Some of these clots can clog the vessels and cut off blood supply to organs such as the liver, brain, or kidneys. Lack of blood flow can damage the organ and it may stop working properly. Over time, the clotting proteins in the blood are consumed or "used up.” When this happens, there is a high risk of serious bleeding, even from a minor injury or without injury.

31 Thrombosis Hemorrhage

32 Bleeding and Thrombotic Disorders
Bleeding disorders von Willebrand disease Hemophilia A and B DIC TTP/HUS Thrombotic Thrombocytopenic Purpura - Hemolytic Uremic Syndrome These cells that form the inside lining of the vessel wall are the “organ” that is abnormal in TTP-HUS. They can be injured by the different causes of TTP-HUS listed below. When these cells are injured, the smooth flow of blood cells is disrupted. Blood platelets are consumed at the many points of injury, because the function of blood platelets is to seal any leaks that occur in blood vessels and prevent bleeding. When these cells are damaged throughout the body, platelets stick to the damaged areas and the platelet count may decrease to very low levels. The platelets can also stick to each other and block blood flow. This is the critical problem that occurs in TTP-HUS; these platelet clumps are the blood clots or thrombi described by the first “T” in TTP.

33 Thrombotic Thrombocytopenic Purpura
Things you must know Pentad: MAHA, thrombocytopenia, fever, neurologic defects, renal failure Deficiency of ADAMTS13 Big vWF multimers trap platelets Plasmapheresis or plasma infusions microangiopathic hemolytic anemia (MAHA) is a microangiopathic subgroup of hemolytic anemia (loss of red blood cells through destruction) caused by factors in the small blood vessels. It is identified by the finding of anemia and schistocytes on microscopy of the blood film.

34 Some types of TTP-HUS have an autoimmune cause, in which the patient makes an antibody that blocks the function of one of their own enzymes, named ADAMTS13. ADAMTS13 is an enzyme in the blood that digests the protein that makes platelets stick together, called von Willebrand factor or VWF. When VWF is made in the cells that line the blood vessel, it is too big. ADAMTS13 is required to cut the VWF into smaller pieces, cutting it down to its normal size. When there is a deficiency of ADAMTS13 enzyme, the VWF is too large and too sticky for platelets. It can cause the platelet clumps that block blood vessels and cause TTP.

35 Rodent of unusual size (ROUS) -The Princess Bride, 1987
Nasty creatures Rodent of unusual size (ROUS) -The Princess Bride, 1987 Von Willebrand multimer of unusual size (MOUS) - NEJM, 1982

36 Thrombotic Thrombocytopenic Purpura
Clinical pentad Hematuria/jaundice (MAHA) Bleeding/bruising (thrombocytopenia) Fever Bizarre behavior (thrombi in CNS) Renal failure (thrombi in kidney) Treatment Plasmapheresis (in acquired TTP) Plasma infusions (in hereditary TTP)

37 Hemolytic Uremic Syndrome
Things you must know MAHA and thrombocytopenia Most are related to E. coli infection Toxin damages endothelium Treat supportively The central pathologic feature of both disorders is the formation of platelet thrombi in the microvasculature which may produce tissue ischemia and infarction. Immunohistochemically, the platelet thrombi contain large amounts of von Willebrand factor (VWF). These thrombi cause shearing stress on the red blood cells passing through the capillaries causing fragmentation ( thrombotic MAHA). The etiology of HUS is unknown. Recent studies have suggested that endothelial cells are damaged, thereby releasing large amounts of abnormal ultralarge VWF multimers into the circulation, which in turn, act as potent platelet aggregators.

38 Bleeding and Thrombotic Disorders
Bleeding disorders von Willebrand disease Hemophilia A and B DIC TTP/HUS ITP

39 Idiopathic Thrombocytopenic Purpura
Things you must know Antiplatelet antibodies coat platelets Splenic macrophages eat platelets Diagnosis of exclusion Steroids or splenectomy Autoimmune disease - Antiplatelet antibodies are produced by B cells and coat platelets so they can no longer work. The typical presentation is bruising in an otherwise healthy person. In patients with ITP, the spleen is considered to be the primary site of platelet destruction and anti-platelet antibody production

40 Bruising after minor trauma in ITP

41 Bleeding and Thrombotic Disorders
Bleeding disorders von Willebrand disease Hemophilia A and B DIC TTP/HUS ITP Thrombotic disorders Factor V Leiden Factor V Leiden is the name of a specific gene mutation that results in thrombophilia, which is an increased tendency to form abnormal blood clots that can block blood vessels. Factor V Leiden thrombophilia is a genetically inherited disorder of blood clotting. Factor V Leiden is a variant (mutated form) of human factor V that causes an increase in blood clotting (hypercoagulability).

42 Factor V Leiden thrombophilia also increases the risk that clots will break away from their original site and travel through the bloodstream. Blood clot sequelae

43 Deep venous thrombosis
People with factor V Leiden thrombophilia have a higher than average risk of developing a type of blood clot called a deep venous thrombosis (DVT). DVTs occur most often in the legs, although they can also occur in other parts of the body, including the brain, eyes, liver, and kidneys. Deep venous thrombosis

44 Deep venous thrombosis

45 Pulmonary embolus

46 Thrombosis Risk Factors
Endothelial damage Atherosclerosis Stasis Immobilization Varicose veins Cardiac dysfunction Hypercoagulability Surgery Carcinoma Estrogen/postpartum Thrombotic disorders

47 When should you worry about a hereditary disorder?
no obvious cause family history weird location recurrent patient is young miscarriages

48 Factor V Leiden Things you must know
Most common cause of unexplained thromboses Inherited point mutation in factor V gene Factor V can’t be turned off High risk of thrombosis if homozygous

49 What is Factor V Leiden? A mutated factor V gene Single point mutation
Discovered in Leiden, Netherlands Produces abnormal factor V Participates in the cascade Can’t be cleaved by protein C Protein C, also known as autoprothrombin IIA and blood coagulation factor XIV, is a zymogen, the activated form of which plays an important role in regulating anticoagulation, inflammation, cell death, and maintaining the permeability of blood vessel walls in humans and other animals. Activated protein C (APC) performs these operations primarily by proteolytically inactivating proteins Factor Va and Factor VIIIa.

50 Yeah, so? You can turn it on… …but you can’t turn it off !

51 Intrinsic Extrinsic TF VII IX VIII X V Va thrombin fibrin clot

52 clot Intrinsic Extrinsic X thrombin fibrin TF VII IX VIII VIIIa V Va
protein C fibrin clot

53 What is the risk of getting a clot?
Heterozygotes: 7 times normal Homozygotes: 80 times normal Normal risk = 5 per 100,000 person-years!

54 Factor V Leiden Diagnosis PTT and INR not helpful Need genetic testing
Treatment Don’t! Unless there is a thrombosis. Then give oral anticoagulants Prothrombin Time and International Normalized Ratio - Prothrombin time (PT) is a blood test that measures how long it takes blood to clot. A PT test may also be called an INR test. INR (international normalized ratio) stands for a way of standardizing the results of prothrombin time tests, no matter the testing method. So your doctor can understand results in the same way even when they come from different labs and different test methods.


Download ppt "Bleeding and Thrombotic Disorders."

Similar presentations


Ads by Google